Cancer Care Research Centre, University of Stirling, Stirling, UK.
Palliat Med. 2011 Jun;25(4):357-64. doi: 10.1177/0269216310391346. Epub 2011 Jan 12.
This paper reports on data from the initial phase of a UK-wide study exploring life-limiting conditions (LLCs) in children where, because of their rarity, little is understood regarding the significant symptom challenges of families and care professionals who support them. In this initial phase, care professionals (n=43) and families (n=16) completed a survey to identify which rare LLCs present symptom challenges and which individual symptoms prove difficult to manage. Findings led to the prioritization of mucopolysaccharidoses, Batten Disease and leukodystrophy. Care professionals' rationales for selecting these conditions included the presence of symptoms that are very difficult to manage, a requirement for additional clinical evidence to support symptom management, and the progressive nature of these diseases where symptoms frequently change and are difficult to predict. Families identified symptoms such as behavioural difficulties, visual impairments and communication impairments as those being most difficult to manage and having most impact on quality of life for children and families.
本文报告了一项英国范围内研究的初始阶段数据,该研究旨在探讨儿童的生命末期疾病(LLC),由于这些疾病较为罕见,对于支持患儿的家庭和医护人员所面临的严重症状挑战,人们知之甚少。在这一初始阶段,医护人员(n=43)和家庭(n=16)完成了一项调查,以确定哪些罕见的 LLC 会带来症状挑战,以及哪些特定症状难以控制。研究结果确定了黏多糖贮积症、Batten 病和白质营养不良为优先研究领域。医护人员选择这些疾病的理由包括存在非常难以控制的症状、需要额外的临床证据来支持症状管理,以及这些疾病的进展性,症状经常变化且难以预测。家庭认为行为困难、视力障碍和沟通障碍等症状是最难控制的,对儿童和家庭的生活质量影响最大。